RION, a commercial and clinical-stage regenerative medicine company, has signed a collaboration with Lonza, one of the world’s largest contract development and manufacturing organisations (CDMOs). The partnership will focus on cGMP manufacturing and technical support for RION’s Purified Exosome Product™
Novopor Advanced Science Private Limited has inaugurated a Pilot Plant Facility at its Vizag Unit-01 (SEZ), enhancing its ability to bridge the gap between research and full-scale manufacturing. The launch took place on 16 September 2025 in Visakhapatnam. The facility
eXmoor Pharma, an integrated cell and gene therapy CDMO with embedded consultancy expertise, has partnered with Siam Bioscience, a biopharmaceutical company in ASEAN, to develop a CGT centre in Bangkok. The collaboration aims to accelerate the growth of the CGT
The U.S. Department of Health and Human Services (HHS), under the Trump administration, announced new autism-related initiatives on September 22, including research into acetaminophen (Tylenol) exposure during pregnancy and use of leucovorin in treatment. The move follows President Trump’s remarks
Aenova, a contract development and manufacturing organisation (CDMO), has announced a major expansion of its microbiology QC laboratory at its Latina site. The new facility will enhance sterility testing for biologics, environmental monitoring, bacterial identification, and advanced techniques for bioburden,
FUJIFILM Biotechnologies, a contract development and manufacturing organisation (CDMO) for biologics, vaccines, and advanced therapies, has provided a $100,000 in-kind donation to North Carolina State University’s Biomanufacturing Training and Education Center (BTEC). The contribution, made in partnership with the North
Enzene, a global continuously innovative development and manufacturing organisation (CIDMO), has started the commercial supply of pertuzumab in India. The monoclonal antibody therapy, used for HER2-positive breast cancer, will be marketed locally by multiple pharmaceutical companies. The therapy was developed
Pfizer Inc. has entered into a definitive agreement to acquire Metsera Inc., a clinical-stage biopharmaceutical company focused on obesity and cardiometabolic diseases, for approximately $4.9 billion. The deal, unanimously approved by the Boards of Directors of both companies, includes a
An analysis of the CDMOs operating facilities in Europe, by Small Molecule, Biologics and Cell & Gene Therapty
Novartis has built up substantial pharmaceutical stockpiles in the United States and announced major manufacturing investments as the Swiss company prepares for potential tariffs under President Trump’s trade policies, CEO Vas Narasimhan revealed on Saturday. Speaking to Swiss newspaper Neue
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
